Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Raised to $40.00
Rhythm Pharmaceuticals (NASDAQ:RYTM – Free Report) had its target price lifted by Wells Fargo & Company from $38.00 to $40.00 in a report issued on Wednesday morning, Benzinga reports. The firm currently has an overweight rating on the stock. A number of other analysts also recently weighed in on the stock. Bank of America raised […]
More Stories
Why Americans Pay High Gas Prices Despite Record U.S. Oil Production and Exports
By Stephen Zogopoulos, USNN World News The Paradox at the Pump As of early May 2026, U.S. regular gasoline prices...
What Time Does Netflix Release Shows? Don’t Miss Another New Release
Many of us like to watch series and movies, but most of the time miss the new release, right? And...
Trump Calls Iran’s Response to Peace Proposal ‘Totally Unacceptable’
By Tom Gantert U.S. President Donald Trump on May 10 rejected Iran’s response to the latest peace proposal pitched by...
Iran Turns to China Rail Link to Bypass US Blockade, but It Has Limited Effect, Analysts Say
By Alex Wu As the U.S. military continues to blockade Iranian ports, Iran has increased overland railway shipment with China...
Passengers Evacuate Cruise Ship Hit by Deadly Hantavirus Outbreak
By Tom Gantert The passengers and crew aboard the MV Hondius exited the hantavirus-stricken cruise ship in the Canary Islands...
Hantavirus Symptoms Reported on Cruise Evacuation Flight
By Tom Gantert A French citizen on the MV Hondius cruise ship came down with hantavirus symptoms while flying back...